116764-34-2

Upstream product

• 3752-24-7 4,5,6,7-tetrahydro-1H-benzimidazole 
• 42075-27-4 3-(4-fluorobenzoyl)butanoic acid 
• 110-91-8 morpholine 
• 4786-20-3 crotononitrile 
• 90514-71-9 4-(4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)benzaldehyde 

Downstream Products

• 97150-57-7 4,5-dihydro-6-[4-(4,5,6,7-tetrahydro-1H-benzimidazol-1-yl)phenyl]-5-methyl-3(2H)-pyridazinone 

Relevant academic research and scientific papers

4,5-dihydro-6-(substituted)phenyl-5-methyl-3-(2H)-pyridazinones and pharmaceutical compositions containing the compounds as active components

A novel method of producing 4,5-dihydro-6-(substituted)phenyl-5-methyl-3(2H)-pyridazinone compounds and the corresponding pharmaceutically acceptable salt compounds is provided as well as pharmaceutical compositions containing one or more of the compounds

Cardiotonic Agents. 2. Synthesis and Structure-Activity Relationships of 4,5-Dihydro-6--3(2H)-pyridazinones: A New Class of Positive Inotropic Agents

A series of 4,5-dihydro-6--3(2H)-pyridazinones and related compounds were synthesized and evaluated for positive inotropic activity.Most members of this series produced dose-related increases in myocardial contractility that we